Trial Profile
A Randomised, Multicentre, Open-Label, Parallel-Group, 24-Week Phase IV Study Comparing the Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care: General Practitioner Initiation of Insulin Glargine Versus the Usual Standard of Care.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2011
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms RELIANCE
- Sponsors Sanofi
- 29 Jul 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 04 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Apr 2010 Planned end date changed from 1 Dec 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.